Percutaneous Sclerotherapy for Treatment of Tumoral Calcinosis |
| |
| Institution: | 1. Institute of Molecular Biology and Genetics, Almazov Federal Heart, Blood and Endocrinology Centre, St. Petersburg, Russia;2. Ariadne Genomics, Rockville, Maryland;3. Center for Molecular Medicine and Division of Vascular Surgery, Karolinska Institutet, SE-171 76 Stockholm, Sweden;4. Department of Molecular Medicine and Surgery, Karolinska Institutet, SE-171 76 Stockholm, Sweden;5. Women’s and Children’s Health, Karolinska Institutet, SE-171 76 Stockholm, Sweden;6. Physiology and Pharmacology, Karolinska Institutet, SE-171 76 Stockholm, Sweden;1. Department of Radiology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China;2. Healthcare Sector, Siemens Limited China, Shanghai, China;3. Healthcare Sector, Siemens AG, Forchheim, Germany;1. Department of Computer Engineering, Technology Faculty, Duzce University, Duzce, Turkey;2. Department of Opticianry, Vocational School of Medical Sciences, Turgut Ozal University, Ankara, Turkey;3. Department of Physics, Faculty of Science and Arts, Gazi University, Ankara, Turkey |
| |
| Abstract: | Massive tumoral calcinosis developed in a 29-year-old woman with type 1 diabetes and failed pancreas and kidney transplant on peritoneal dialysis. The patient had a symptomatic calcified, fluid-filled posterior thigh mass. After percutaneous drainage of 260 mL of milky fluid, she had rapid recurrence of the collection. She underwent catheter-based sclerotherapy first with 110 mL of povidone-iodine followed 2 days later by 40 mL of 3% sodium tetradecyl sulfate foam. At 5.5 months after the procedure, the patient remained asymptomatic, and computed tomography imaging showed complete resolution of the collection. |
| |
| Keywords: | PTH"} {"#name":"keyword" "$":{"id":"key0010"} "$$":[{"#name":"text" "_":"parathyroid hormone |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
